Dialysis Devices Market

By Product Type;

Hemodialysis Machines, Peritoneal Dialysis Machines, Continuous Renal Replacement Therapy Machines and Consumables

By Mobility;

Stationary Dialysis Device and Portable Dialysis Device

By End User;

Hospitals, Dialysis Centers and Homecare Settings

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn212080003 Published Date: September, 2025 Updated Date: November, 2025

Dialysis Machines Market Overview

Dialysis Machines Market (USD Million)

Dialysis Machines Market was valued at USD 18,445.28 million in the year 2024. The size of this market is expected to increase to USD 25,529.98 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.8%.


Dialysis Devices Market

*Market size in USD million

CAGR 4.8 %


Study Period2025 - 2031
Base Year2024
CAGR (%)4.8 %
Market Size (2024)USD 18,445.28 Million
Market Size (2031)USD 25,529.98 Million
Market ConcentrationHigh
Report Pages337
18,445.28
2024
25,529.98
2031

Major Players

  • Fresenius Medical Care AG & Co. KGaA
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Nikkiso Co., Ltd.
  • Asahi Kasei Corporation
  • Nipro Corporation
  • DaVita Inc.
  • NxStage Medical, Inc.
  • Allmed Medical GmbH
  • Toray Industries, Inc.

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Dialysis Devices Market

Fragmented - Highly competitive market without dominant players


The Dialysis Devices Market is expanding steadily, fueled by the rising burden of kidney-related disorders and demand for effective treatment solutions. These devices play a crucial role in eliminating toxins, waste, and fluids from the blood for patients with renal failure. Nearly 65% of individuals with chronic kidney disease depend on dialysis, emphasizing the growing reliance on advanced devices.

Advancements in Technology
Continuous improvements in automated dialysis machines, compact systems, and biocompatible devices are shaping market growth. Approximately 45% of service providers have adopted advanced dialysis technologies that enhance safety, precision, and efficiency. Integration of digital monitoring and innovative materials is redefining treatment experiences for both patients and providers.

Shift Toward Home Dialysis
Home-based dialysis is gaining momentum, with nearly 40% of patients opting for portable and convenient devices that allow treatment outside hospital environments. These systems enhance patient independence and lifestyle flexibility, reducing the physical and emotional burden of frequent hospital visits. This trend reflects the rising emphasis on personalized renal care.

Outlook and Opportunities
The future of the dialysis devices market remains strong, supported by progress in wearable technologies, connected solutions, and patient-centered innovations. Nearly 55% of patients are expected to transition to next-generation systems offering enhanced comfort and better outcomes. Continued investment in research will ensure dialysis devices remain a lifesaving and indispensable therapy for kidney patients.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Mobility
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Dialysis Machines Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Technological innovation
        2. Increasing prevalence
        3. Aging population
        4. Government support
        5. Patient education
      2. Restraints
        1. Costly treatment
        2. Limited accessibility
        3. Regulatory challenges
        4. Staff shortage
        5. Infection risks
      3. Opportunities
        1. Home dialysis expansion
        2. Telemedicine integration
        3. Emerging markets growth
        4. Personalized therapies
        5. Portable devices development
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Dialysis Devices Market, By Product Type, 2021 - 2031 (USD Million)
      1. Hemodialysis Machines
      2. Peritoneal Dialysis Machines
      3. Continuous Renal Replacement Therapy Machines
      4. Consumables
    2. Dialysis Devices Market, By Mobility, 2021 - 2031 (USD Million)
      1. Stationary Dialysis Device
      2. Portable Dialysis Device
    3. Dialysis Devices Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Dialysis Centers
      3. Homecare Settings
    4. Dialysis Machines Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Fresenius Medical Care
      2. Baxter International Inc.
      3. B. Braun Melsungen AG
      4. Asahi Kasei Corporation
      5. Nipro Corporation
      6. Nikkiso Co., Ltd.
      7. Teleflex Incorporated
      8. Rockwell Medical
      9. Quanta Dialysis Technologies
      10. Toray Medical Co., Ltd.
      11. Hemoclean Co. Ltd.
      12. NxStage Medical, Inc.
      13. Medivators Inc.
      14. Terumo Corporation
      15. Quanta / Nanodialysis BV
  7. Analyst Views
  8. Future Outlook of the Market